Development of new fluorescence diagnosis in breast cancer

Development of new fluorescence diagnosis in breast cancer - Development of new fluorescence diagnosis in breast cancer

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029266

Enrollment

Registered

2017-10-01

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who suspected of breast cancer Patients who diagnosed with operable breast cancer Patients who provided signed informed consent

Exclusion criteria

Exclusion criteria: Patients who is determined inappropriate to participate in the study by the attending physician Patients with inoperable advanced recurrent breast cancer

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity of primary tumor and lymph node metastasis using fluorescence diagnosticssa	—

Secondary

Measure	Time frame
The comparison to the difference in fluorescence between normal and cancer cells, The comparison to the difference in fluorescence between normal and metastatic lymph nodes, Analysis by breast cancer subtype	—

Countries

Japan

Contacts

Public ContactMidori Morita

Kyoto Prefectural University of Medicine Endocrine & Breast Surgery

midori@koto.kpu-m.ac.jp+81-75-251-5534

Outcome results